<p>HR: hazard ratio, CI: confidence interval, ESS: endometrial stromal sarcoma, LGESS: low grade endometrial stromal sarcoma, LMS: leiomyosarcoma.</p
<p>Abbreviations: HR = hazard ratio, CI = confidence interval.</p><p>Univariate and multivariate Cox...
PURPOSE: To correlate the treatment used in uterine sarcoma with outcome. The prognostic importance...
<p>Abbreviations: OS, overall survival; EFS, event-free survival; HR, hazard ratio; 95% CI, 95% conf...
<p>CRP: C-reactive protein, OS: overall survival, FIGO: International Federation of Obstetrics and G...
To determine independent prognostic factors for the survival of patients with endometrial stromal sa...
To examine the histopathological features and treatment modalities in patients with uterine sarcoma ...
Objective To determine the survival data for the various tumour types of uterine sarcoma and determi...
<p>*For DFS, the multivariate model included Stage 1C, II, III/IV, grade 2 and 3.</p><p>**For OS, th...
The present study aimed to assess the diagnosis, treatment and follow‑up of uterine sarcoma cases. A...
<p>ESS: endometrial stromal sarcoma, LGESS: low grade endometrial stromal sarcoma, LMS: leiomyosarco...
<p>SE: standard error; <i>P-v</i>: P value; HR: hazard ratios; CI: confidence interval.</p><p>Multiv...
Background: Uterine sarcomas are rare, malignant, gynecological tumors and show diverse histopatholo...
Objective: The aim of this study was to compare the survival durations of patients with uterine carc...
The World Health Organization (WHO 2003) recognizes 3 endometrial stromal neoplasms: noninvasive end...
<p>CI = confidence interval; HR = hazards ratio;</p>*<p>HR was calculated Stage III vs. Stage I-II;*...
<p>Abbreviations: HR = hazard ratio, CI = confidence interval.</p><p>Univariate and multivariate Cox...
PURPOSE: To correlate the treatment used in uterine sarcoma with outcome. The prognostic importance...
<p>Abbreviations: OS, overall survival; EFS, event-free survival; HR, hazard ratio; 95% CI, 95% conf...
<p>CRP: C-reactive protein, OS: overall survival, FIGO: International Federation of Obstetrics and G...
To determine independent prognostic factors for the survival of patients with endometrial stromal sa...
To examine the histopathological features and treatment modalities in patients with uterine sarcoma ...
Objective To determine the survival data for the various tumour types of uterine sarcoma and determi...
<p>*For DFS, the multivariate model included Stage 1C, II, III/IV, grade 2 and 3.</p><p>**For OS, th...
The present study aimed to assess the diagnosis, treatment and follow‑up of uterine sarcoma cases. A...
<p>ESS: endometrial stromal sarcoma, LGESS: low grade endometrial stromal sarcoma, LMS: leiomyosarco...
<p>SE: standard error; <i>P-v</i>: P value; HR: hazard ratios; CI: confidence interval.</p><p>Multiv...
Background: Uterine sarcomas are rare, malignant, gynecological tumors and show diverse histopatholo...
Objective: The aim of this study was to compare the survival durations of patients with uterine carc...
The World Health Organization (WHO 2003) recognizes 3 endometrial stromal neoplasms: noninvasive end...
<p>CI = confidence interval; HR = hazards ratio;</p>*<p>HR was calculated Stage III vs. Stage I-II;*...
<p>Abbreviations: HR = hazard ratio, CI = confidence interval.</p><p>Univariate and multivariate Cox...
PURPOSE: To correlate the treatment used in uterine sarcoma with outcome. The prognostic importance...
<p>Abbreviations: OS, overall survival; EFS, event-free survival; HR, hazard ratio; 95% CI, 95% conf...